Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to -$2.8 million.

  • AVITA Medical's Free Cash Flow fell 13184.18% to -$2.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$30.2 million, marking a year-over-year increase of 2408.47%. This contributed to the annual value of -$30.2 million for FY2025, which is 2408.47% up from last year.
  • As of Q4 2025, AVITA Medical's Free Cash Flow stood at -$2.8 million, which was down 13184.18% from -$6.2 million recorded in Q3 2025.
  • AVITA Medical's 5-year Free Cash Flow high stood at $8.6 million for Q4 2024, and its period low was -$22.0 million during Q1 2024.
  • For the 5-year period, AVITA Medical's Free Cash Flow averaged around -$8.0 million, with its median value being -$9.4 million (2022).
  • In the last 5 years, AVITA Medical's Free Cash Flow crashed by 212586.21% in 2023 and then skyrocketed by 17750.69% in 2024.
  • Over the past 5 years, AVITA Medical's Free Cash Flow (Quarter) stood at -$639000.0 in 2021, then tumbled by 448.67% to -$3.5 million in 2022, then crashed by 218.28% to -$11.2 million in 2023, then skyrocketed by 177.51% to $8.6 million in 2024, then plummeted by 131.84% to -$2.8 million in 2025.
  • Its Free Cash Flow was -$2.8 million in Q4 2025, compared to -$6.2 million in Q3 2025 and -$10.8 million in Q2 2025.